vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and TANGER INC. (SKT). Click either name above to swap in a different company.
TANGER INC. is the larger business by last-quarter revenue ($150.4M vs $75.5M, roughly 2.0× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 11.1%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 8.0%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Tanger Inc. is a real estate investment trust headquartered in Greensboro, North Carolina, that invests in open air outlet and lifestyle shopping centers in the United States and Canada.
PBYI vs SKT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $150.4M |
| Net Profit | — | $29.4M |
| Gross Margin | 69.3% | — |
| Operating Margin | 22.7% | — |
| Net Margin | — | 19.6% |
| Revenue YoY | 27.7% | 11.1% |
| Net Profit YoY | — | 47.1% |
| EPS (diluted) | $0.26 | $1.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $150.4M | ||
| Q4 25 | $75.5M | $151.0M | ||
| Q3 25 | $54.5M | $145.2M | ||
| Q2 25 | $52.4M | $140.7M | ||
| Q1 25 | $46.0M | $135.4M | ||
| Q4 24 | $59.1M | $132.2M | ||
| Q3 24 | $80.5M | $133.0M | ||
| Q2 24 | $47.1M | $129.0M |
| Q1 26 | — | $29.4M | ||
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $32.0M | ||
| Q2 25 | $5.9M | $30.1M | ||
| Q1 25 | $3.0M | $19.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $24.9M | ||
| Q2 24 | $-4.5M | $24.8M |
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | — | ||
| Q3 25 | 17.6% | 20.1% | ||
| Q2 25 | 12.7% | 20.1% | ||
| Q1 25 | 8.7% | 13.0% | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | 17.8% | ||
| Q2 24 | -4.6% | 17.8% |
| Q1 26 | — | 19.6% | ||
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | 22.1% | ||
| Q2 25 | 11.2% | 21.4% | ||
| Q1 25 | 6.5% | 14.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 18.7% | ||
| Q2 24 | -9.6% | 19.3% |
| Q1 26 | — | $1.05 | ||
| Q4 25 | $0.26 | — | ||
| Q3 25 | $0.17 | $0.28 | ||
| Q2 25 | $0.12 | $0.26 | ||
| Q1 25 | $0.06 | $0.17 | ||
| Q4 24 | $0.40 | — | ||
| Q3 24 | $0.41 | $0.22 | ||
| Q2 24 | $-0.09 | $0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $227.4M |
| Total DebtLower is stronger | $22.7M | — |
| Stockholders' EquityBook value | $130.3M | $697.8M |
| Total Assets | $216.3M | $2.8B |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $227.4M | ||
| Q4 25 | $97.5M | $18.1M | ||
| Q3 25 | $94.4M | $13.0M | ||
| Q2 25 | $96.0M | $9.7M | ||
| Q1 25 | $93.2M | $10.2M | ||
| Q4 24 | $101.0M | $47.0M | ||
| Q3 24 | $96.7M | $11.1M | ||
| Q2 24 | $96.8M | $11.3M |
| Q1 26 | — | — | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | $1.6B | ||
| Q2 25 | $45.3M | $1.5B | ||
| Q1 25 | $56.7M | $1.6B | ||
| Q4 24 | $68.0M | $1.4B | ||
| Q3 24 | $79.3M | $1.4B | ||
| Q2 24 | $90.7M | $1.5B |
| Q1 26 | — | $697.8M | ||
| Q4 25 | $130.3M | — | ||
| Q3 25 | $115.3M | $703.6M | ||
| Q2 25 | $104.7M | $635.2M | ||
| Q1 25 | $97.1M | $633.9M | ||
| Q4 24 | $92.1M | $652.4M | ||
| Q3 24 | $71.1M | $568.3M | ||
| Q2 24 | $48.5M | $553.7M |
| Q1 26 | — | $2.8B | ||
| Q4 25 | $216.3M | — | ||
| Q3 25 | $202.9M | $2.6B | ||
| Q2 25 | $194.9M | $2.5B | ||
| Q1 25 | $196.2M | $2.5B | ||
| Q4 24 | $213.3M | $2.4B | ||
| Q3 24 | $220.7M | $2.3B | ||
| Q2 24 | $205.0M | $2.3B |
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | 2.29× | ||
| Q2 25 | 0.43× | 2.40× | ||
| Q1 25 | 0.58× | 2.47× | ||
| Q4 24 | 0.74× | 2.18× | ||
| Q3 24 | 1.12× | 2.51× | ||
| Q2 24 | 1.87× | 2.64× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | — |
| Free Cash FlowOCF − Capex | $14.4M | — |
| FCF MarginFCF / Revenue | 19.1% | — |
| Capex IntensityCapex / Revenue | 0.0% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | $74.3M | ||
| Q2 25 | $14.1M | $82.0M | ||
| Q1 25 | $3.6M | $41.4M | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | $65.2M | ||
| Q2 24 | $1.0M | $72.8M |
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | 6.6% | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 2.32× | ||
| Q2 25 | 2.41× | 2.73× | ||
| Q1 25 | 1.21× | 2.16× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | 2.62× | ||
| Q2 24 | — | 2.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
SKT
| Rental revenue | $143.5M | 95% |
| Other revenue | $4.7M | 3% |
| Management, leasing and other services | $2.2M | 1% |
